Company intelligence / Profile preview

Pandora

Ownership: Public · PNDORA
Development stage: Commercial

Overview

Pandora Biosciences provides an AI-powered platform that integrates diverse, multi-modal patient datasets to accelerate the development of diagnostics and therapeutics for chronic diseases. The company partners with pharmaceutical and biotech firms to improve R&D outcomes but does not appear to have its own clinical pipeline or published clinical results yet.

Therapeutic areas: Other
Modalities: Non-pharmacological therapy (Diagnostics)Digital health platform
Industry: Drug Discovery Services

Partnerships

Pharma and biotech companies (R&D enablement)

Financials

Market cap: $61.5B
Total revenue: $20.8B

Beyond the preview

Go deeper on Pandora.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pandora.

Explore the full profile